HY2CARE
Hy2Care BV is a business start-up of the University of Twente, the Netherlands. It is Hy2Care’s ambition to introduce into the market the first cure for Osteoarthritis, the injectable hydrogel. Osteoarthritis is the 4th leading cause of mobility associated disability and affects more than 100 million patients in the Western world, who are all in need for an effective treatment. It is the aim of Hy2Care to change the future for patients suffering from osteoarthritis.
HY2CARE
Industry:
Health Care Medical Medical Device
Founded:
2014-12-05
Address:
Enschede, Overijssel, The Netherlands
Country:
The Netherlands
Website Url:
http://www.hy2care.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
9.72 M EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Google Universal Analytics Domain Not Resolving Mobile Non Scaleable Content Euro Google Analytics IP Anonymization Google Analytics Forced SSL
Similar Organizations
Cara Care
Cara Care is a digital gut health platform that offers an app-based treatment to help patients with chronic gastrointestinal problems.
CeQur
CeQur develops and commercializes insulin delivery systems, giving people with type 2 diabetes freedom from multiple daily injections.
Equinox
Equinox is a developer of a medical technology in revolutionizing the treatment of glaucoma and other progressive eye diseases.
Sensome
Sensome offers micro-sensor technology to turn medical devices into connected healthcare devices.
LipoCoat
LipoCoat is a spin-off company from the University of Twente that develops bio-inspired coatings for healthcare.
VeeOne Health
VeeOne Health is a virtual healthcare technology & services company, specializing in advanced Telemedicine and Virtual Healthcare services.
Current Employees Featured
Founder
Investors List
European Innovation Council
European Innovation Council investment in Grant - Hy2Care
Brightlands Venture Partners
Brightlands Venture Partners investment in Series A - Hy2Care
ReumaNederland
ReumaNederland investment in Series A - Hy2Care
Startupbootcamp
Startupbootcamp investment in Seed Round - Hy2Care
Startupbootcamp Smart Materials
Startupbootcamp Smart Materials investment in Seed Round - Hy2Care
Newest Events participated
Participated in Startupbootcamp Smart Materials 2015 Demo Day
on 2015-07-10 as exhibitor
Official Site Inspections
http://www.hy2care.com Semrush global rank: 2.89 M Semrush visits lastest month: 5.61 K
- Host name: vps09.syveon.com
- IP address: 87.253.157.249
- Location: Netherlands
- Latitude: 52.3824
- Longitude: 4.8995
- Timezone: Europe/Amsterdam
More informations about "Hy2Care"
Hy2Care® | Hydrogel implant for enabling cartilage …
The unique composition of Hy2Care’s CartRevive® hydrogel implant creates a natural scaffold for the patient’s own cells to reside in and deposit new cartilage matrix, enabling the body to heal itself. About our technology. Sanne's Story. …See details»
Hy2Care - Crunchbase Company Profile & Funding
Hy2Care BV is a business start-up of the University of Twente, the Netherlands. It is Hy2Care’s ambition to introduce into the market the first cure for Osteoarthritis, the injectable hydrogel. Osteoarthritis is the 4th leading cause of mobility …See details»
HY2Care Company Profile 2024: Valuation, Funding
HY2Care General Information Description. Manufacturer of an injectable hydrogel designed to repair cartilage defects. The company's two-component injectable and bioresorbable hydrogel are composed of a mixture of natural polymer …See details»
Hy2Care - Org Chart, Teams, Culture & Jobs | The Org
View Hy2Care's up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
Hy2Care® BV - LinkedIn
Hy2Care® is a spin-off company of the MIRA Institute of the University Twente, the Netherlands, one of the world’s leading institutes in biomedical and chemical engineering.See details»
Hy2Care - Overview, News & Similar companies | ZoomInfo.com
Hy2Care develops in situ gelating bioresorbable hydrogels for the arthroscopic treatment of cartilage defects, aiming at functional cartilage repai r. Read more. Hy2Care's Social Media. Is …See details»
Hy2Care Company Profile - Office Locations, Competitors ... - Craft
Hy2Care has 5 employees across 2 locations and $4.16 m in total funding,. See insights on Hy2Care including office locations, competitors, revenue, financials, executives, subsidiaries …See details»
Hy2Care - Funding, Financials, Valuation & Investors - Crunchbase
Hy2Care BV develops a novel technology platform consisting of injectable hydrogels to fight osteoarthritis. Search Crunchbase. Start Free Trial . Chrome Extension. ... How much funding …See details»
Hy2Care - Company Profile - Tracxn
Aug 25, 2024 Hy2Care - Developer of injectable hydrogel for treatment of cartilage disorders. Raised a total funding of $10.5M over 3 rounds from 3 investors. Hy2Care has 4 competitors.See details»
Hy2Care - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Nov 10, 2024 Hy2Care BV develops a novel technology platform consisting of injectable hydrogels to fight osteoarthritisSee details»
HY2CARE BV - VentureRadar
" Hy2Care is a ‘spin-off company’ of the MIRA Institute for Biomedical Technology and Technical Medicine of the University of Twente, the Netherlands. Based on a proprietary technology …See details»
☑️Hy2Care — Consulting Organization from the
Hy2Care BV is a spin-off company of the MIRA Institute of the University Twente, the Netherlands, one of the world’s leading institutes in biomedical and chemical engineering. …See details»
Team - Hy2Care
Cookies. Let us know which cookies we may place. When clicking ‘Essential cookies’, we do not collect personal data and you help us to improve the site.See details»
Hy2Care raises € 3.7 mln for hydrogel technology to repair …
Enschede / Sittard-Geleen, 30-04-2019. Hy2Care brengt € 3.7 mln bijeen voor hydrogeltechnologie die kraakbeen repareert. Enschede / Sittard-Geleen, 30-04-2019 – …See details»
Hy2Care - Contacts, Employees, Board Members, Advisors & Alumni
Hy2Care BV develops a novel technology platform consisting of injectable hydrogels to fight osteoarthritisSee details»
Hy2Care - Brightlands Venture Partners
Hy2Care is developing a two-component injectable and bioresorbable hydrogel for the treatment of cartilage defects. The first application is aimed at the functional repair of cartilage defects in …See details»
Watch this video and discover the journey of Hy2Care® as …
Oct 25, 2023 On 19 September 2023, Leo Smit (CEO Hy2Care) shared the story of Hy2Care’s CartRevive™ hydrogel implant to a public of leading healthcare investors, underlining the …See details»
Contact - Hy2Care
[email protected]. Brightlands Chemelot Campus. Urmonderbaan 22 6167 RD GELEEN [email protected]. Contact Hy2Care® ...See details»
Technology - Hy2Care
Hy2Care’s proprietary technology platform is based on the in-situ formation of the CartRevive® hydrogel implant. Two naturally derived polymers – Dextran and Hyaluronic acid conjugates– …See details»